MENEGHETTI, FIORELLA
MENEGHETTI, FIORELLA
Dipartimento di Scienze Farmaceutiche
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
2025 M. Lusardi, E. Morretta, A. Spallarossa, M. Chiara Monti, C. Rosano, E. Iervasi, M. Ponassi, M. Mori, F. Meneghetti, C. Brullo
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
2025 G. Cazzaniga, D. Capelli, R. Montanari, E.M.A. Fassi, G. Grazioso, A. Tresoldi, F. Rinaldi, E. Calleri, I. Bassanini, S. Romeo, M. Garofalo, M. Mori, F. Meneghetti, S. Villa
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)‐N'‐Benzylidenepyrazine‐2‐Carbohydrazides and their Derivatives
2025 P. Houngbedji, D.E. Nawrot, O. Janďourek, K. Konečná, M. Novák, P. Paterová, P. Bárta, M.H. Rambaher, E. Novotná, C. Castellano, M. Mori, F. Meneghetti, M. Záhorszká, J. Korduláková, J. Zitko
Synthesis and crystallographic investigation of two new neutral Ir(III) complexes bearing 6-(phenyl)phenanthridine ligands
2025 L. Menduti, M. Mori, X. Zhou, N. Quadrio, F. Meneghetti, L. De Cola
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation
2025 M. Mori, E.M.A. Fassi, F. Villa, E.G. Milano, F. Forlani, F. Cappitelli, A. Ratti, F. Meneghetti, G. Roda, G. Grazioso, S. Villa
Novel quinazolinones active against multidrug‐resistant Mycobacterium tuberculosis: synthesis, antimicrobial evaluation and in silico exploration of PonA1 as a potential target
2025 M. Kerda, D. Nawrot, P. Slechta, M. Domanský, A. Askari, H. Kamangar, O. Janďourek, K. Konečná, P. Paterová, I. Hlbočanová, M. Macháček, M. Mori, F. Meneghetti, M. Doležal, J. Zitko, G. Bouz
Repurposing of FDA‐Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach
2025 G. Stelitano, C. Bettoni, M. Mori, M. Cocorullo, A. Tresoldi, F. Meneghetti, S. Villa, L.R. Chiarelli
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
2025 G. Cazzaniga, M. Mori, A. Griego, E. Scarpa, G. Moschetti, S. Muzzioli, G. Stelitano, L.R. Chiarelli, M. Cocorullo, E. Casali, A. Porta, G. Zanoni, A. Tresoldi, E. Pini, Í.L. Batalha, G. Battaglia, T. Tuccinardi, L. Rizzello, S. Villa, F. Meneghetti
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
2024 M. Mori, M. Cocorullo, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G.F. Mangiatordi, M. Garofalo, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity
2024 V. Sukanth Kumar Pallabothula, N. Taimur Abdalrahman, M. Mori, A. Hossein Fekri, O. Janďourek, K. Konečná, P. Paterová, M. Novák, P. Dudášová-Hatoková, P. Štěrbová-Kovaříková, C. Castellano, F. Meneghetti, S. Villa, J. Kuneš, M. Juhás, J. Zitko
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients
2024 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis
2024 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids
2024 G. Cazzaniga, A. Tresoldi, A. Gelain, F. Meneghetti, M. Mori, S. Villa
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists
2024 S. Ciceri, E.M.A. Fassi, V. Vezzoli, M. Bonomi, D. Colombo, P. Ferraboschi, G. Grazioso, P. Grisenti, S. Villa, C. Castellano, F. Meneghetti
A new class of GnRH receptor modulators endowed with atropisomerism
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Insights on the atropisomeric properties of elagolix and its derivatives
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB
2023 M. Mori, G. Cazzaniga, A. Tresoldi, A. Gelain, L.R. Chiarelli, G. Stelitano, M. Bellinzoni, S. Villa, F. Meneghetti
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
2023 S. Ciceri, D.R. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, M. Iannone, C. Castellano, F. Meneghetti
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS.
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa